C12Y 301/22004
Crossover junction endodeoxyribonuclease
Official title: Crossover junction endodeoxyribonuclease (3.1.22.4)
C12Y301/22004 (Crossover junction endodeoxyribonuclease) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 5
- Assignees
- 3
- Inventors
- 7
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 3 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Gene Targeting13 Feb 2025US 2025/0051789 A1Algentech SAS
- Compositions and methods for enzymatic disruption of bacterial biofilms4 Nov 2021US 2021/0338783 A1Research Institute At Nationwide Children's Hospital
- Gene Targeting29 Jul 2021US 2021/0230615 A1Algentech SAS
- Engineered dcas9 with reduced toxicity and its use in genetic circuits18 Mar 2021US 2021/0079404 A9Massachusetts Institute of Technology
- Engineered dcas9 with reduced toxicity and its use in genetic circuits26 Mar 2020US 2020/0095589 A1Massachusetts Institute of Technology
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.